AjitSManiamMD

Oncology • Anaheim, CA

Physician

Join to view full profile

Dr. Maniam is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Maniam's full profile

Already have an account?

Office
1801 W Romneya Dr
Ste#203
Anaheim, CA 92801
Phone+1 714-999-1465

Fax+1 714-999-1701

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1992 - 1995
AtlantiCare Regional Medical CenterResidency, Internal Medicine, 1989 - 1992
Madras Medical CollegeClass of 1982

Certifications & Licensure

TX State Medical License 2022 - 2026
CA State Medical License 1996 - 2025
NJ State Medical License 1990 - 1999
PA State Medical License 1992 - 1996
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study Start of enrollment: 2010 Mar 22
Completed
Phase 2
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
Completed
Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome. Start of enrollment: 2014 Jan 28
Completed
Phase 2
Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer Start of enrollment: 2020 May 28
Active, not recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

70 citations
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial.
James Chih-Hsin Yang, D. Ross Camidge, Cheng-Ta Yang, Jianying Zhou, Renhua Guo
Journal of Thoracic Oncology. 2020-12-01
14 citations
A Randomized, Open-Label, Multicenter Trial of Immediate Versus Delayed Intervention with Darbepoetin Alfa for Chemotherapy-Induced Anemia
Veena Charu, Bruce Saidman, Ali Ben-Jacob, Glen R. Justice, Ajit S. Maniam
The Oncologist. 2007-10-01